Science Matters: Setting The Stage For Using Wearables In Oncology Drug Development

Digital biomarkers using data collected with wearable devices are making their way into clinical trials, largely in cardiovascular, respiratory and rare disease settings around physical activity metrics.

Lightbulb
• Source: Shutterstock

[Editor's Note: This article originally appeared on 16 October in In VivoMedtech Insight's sister publication.

Applications in oncology are moving at a more deliberate pace owing to the distinctive nature of cancer patients’ needs. Less...

More from Digital Technologies

More from Medtech Insight